Classical and Nonclassical Class I Major Histocompatibility Complex Molecules Exhibit Subtle Conformational Differences That Affect Binding to CD8αα*
暂无分享,去创建一个
David I. Stuart | Bent K. Jakobsen | Christopher A. O'Callaghan | George F. Gao | D. Stuart | G. Gao | J. Bell | J. Boulter | B. Jakobsen | E. Jones | P. A. van der Merwe | C. O'Callaghan | B. Willcox | J. Wyer | K. Maenaka | E. Yvonne Jones | Katsumi Maenaka | Jonathan M. Boulter | John I. Bell | Benjamin E. Willcox | Jessica R. Wyer | P. Anton Van Der Merwe | David I. Stuart | E. Y. Jones | John I. Bell | George F. Gao | Christopher A. O'Callaghan
[1] D. Stuart,et al. Production, crystallization, and preliminary X‐ray analysis of the human MHC class Ib molecule HLA‐E , 1998, Protein science : a publication of the Protein Society.
[2] M. Petzl-Erler,et al. Interactions of HLA-B*4801 with peptide and CD8. , 1997, Tissue antigens.
[3] P. Parham,et al. Polymorphism in the α3 domain of HLA-A molecules affects binding to CD8 , 1989, Nature.
[4] P. Parham,et al. Nature of polymorphism in HLA-A, -B, and -C molecules. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[5] P. Parham,et al. Cell-cell adhesion mediated by CD8 and MHC class I molecules , 1988, Nature.
[6] G. Gao,et al. Assembly and crystallization of the complex between the human T cell coreceptor CD8α homodimer and HLA‐A2 , 1998, Protein science : a publication of the Protein Society.
[7] D I Stuart,et al. Crystal structure of cat muscle pyruvate kinase at a resolution of 2.6 A. , 1979, Journal of molecular biology.
[8] J. Bell,et al. Structure and function of the human MHC class Ib molecules HLA‐E, HLA‐F and HLA‐G , 1998, Immunological reviews.
[9] F. Studier,et al. Use of T7 RNA polymerase to direct expression of cloned genes. , 1990, Methods in enzymology.
[10] H. Rammensee,et al. Nonclassical HLA-G molecules are classical peptide presenters , 1996, Current Biology.
[11] L. Lanier,et al. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. , 1997, Journal of immunology.
[12] T. Potter,et al. Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[13] J. Bell,et al. Engagement of a T cell receptor by major histocompatibility complex irrespective of peptide , 1997, European journal of immunology.
[14] D. Wiley,et al. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[15] L. Hood,et al. Negative and positive selection of antigen-specific cytotoxic T lymphocytes affected by the α3 domain of MHC I molecules , 1991, Nature.
[16] D. Littman. The structure of the CD4 and CD8 genes. , 1987, Annual review of immunology.
[17] D. Stuart,et al. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. , 1998, Molecular cell.
[18] A. Smolyar,et al. Structural Basis of CD8 Coreceptor Function Revealed by Crystallographic Analysis of a Murine CD8αα Ectodomain Fragment in Complex with H-2Kb , 1998 .
[19] P. Parham,et al. A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2 , 1990, Nature.
[20] R M Esnouf,et al. Further additions to MolScript version 1.4, including reading and contouring of electron-density maps. , 1999, Acta crystallographica. Section D, Biological crystallography.
[21] T. Mak,et al. CD8 is needed for development of cytotoxic T but not helper T cells , 1991, Cell.
[22] N. Holmes,et al. Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. , 1994, Cellular immunology.
[23] S. Christmas,et al. Phenotypic and functional cellular differences between human CD3- decidual and peripheral blood leukocytes. , 1994, Journal of immunology.
[24] B K Jakobsen,et al. TCR binding to peptide-MHC stabilizes a flexible recognition interface. , 1999, Immunity.
[25] J. Bell,et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.
[26] C. Janeway. The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation. , 1992, Annual review of immunology.
[27] S. Meuer,et al. Expression of different CD8 isoforms on distinct human lymphocyte subpopulations , 1991, European journal of immunology.
[28] G. Evans,et al. Co-engagement of CD8 with the T cell receptor is required for negative selection , 1991, Nature.
[29] P. Kavathas,et al. Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class 1 molecule on cytotrophoblasts , 1991, The Journal of experimental medicine.
[30] E A Merritt,et al. Raster3D Version 2.0. A program for photorealistic molecular graphics. , 1994, Acta crystallographica. Section D, Biological crystallography.
[31] B K Jakobsen,et al. T cell receptor and coreceptor CD8 alphaalpha bind peptide-MHC independently and with distinct kinetics. , 1999, Immunity.
[32] P. Parham,et al. CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68. 1 , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[33] D I Stuart,et al. An altered position of the alpha 2 helix of MHC class I is revealed by the crystal structure of HLA-B*3501. , 1996, Immunity.
[34] D. Littman,et al. Requirement for CD8-major histocompatibility complex class I interaction in positive and negative selection of developing T cells , 1992, The Journal of experimental medicine.
[35] A. Kruisbeek,et al. CD4 and CD8 act as co-receptors during thymic selection of the T cell repertoire. , 1991, Seminars in immunology.
[36] J. Bajorath,et al. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. , 1995, Immunity.